FDA clears Tandem Diabetes iPhone and Android app for insulin doses
Add a feature to the technological Swiss army knife that is your smartphone: the ability to deliver insulin doses.
The Food and Drug Administration has licensed the first app for iPhone and Android devices capable of giving diabetic patients doses of insulin.
In a statement, Tandem Diabetes Care confirmed that its t:connect mobile app, which pairs with the company’s t:slim X2 insulin pump, will allow diabetic users to administer a dose of insulin directly through their smartphone. .
The feature is used for bolus insulin dosing, the company said. According to non-profit organization Beyond Type 1, bolus insulin is a type of insulin taken to prevent spikes in glucose after meals.
“LEGAL EXTORTION”: Diabetics pay high price for insulin as discounts drive up costs
“This FDA clearance further validates our commitment to innovation and the diabetes community by providing one of the most requested feature enhancements,” said John Sheridan, president and CEO of Tandem Diabetes Care in a statement. communicated.
The FDA-cleared feature will be available for free via software update. The company hasn’t said when the feature will launch.
Follow Brett Molina on Twitter: @brettmolina23.
THINK THE WORD IS TOO EASY? : Quordle gives you four daily puzzles to solve at once
SECRET TREASURES: Hidden apps on your smartphone and how to find them